Study Phase III Study to Assess the Efficacy and Safety of SOTB07 in Asthma Patients

Condition:   Asthma
Interventions:   Drug: SOTB07 200mg;   Drug: SOTB07 400mg;   Drug: placebo
Sponsors:   SK Chemicals Co.,Ltd.;   SK Chemicals Co.,Ltd.
Recruiting – verified July 2013

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.